Jeff frequently represents corporations, directors, and officers in high-stakes litigation, investigations, and enforcement actions.
Expertise
Experience
Representative matters
The special litigation committee of the board of directors of a pharmaceutical company in connection with shareholder derivative litigation.
The board of directors of an electric utility company in connection with shareholder derivative litigation.
A multinational financial institution in several mortgage-backed securities cases.
A committee of the board of directors of a pharmaceutical company in connection with shareholder derivative litigation.
A major health insurance provider in connection with a contract dispute.
A pharmaceutical company in a securities class action involving allegations of antitrust violations in connection with the marketing of pharmaceuticals.
An investment fund in connection with a government investigation.
The underwriters in securities litigation related to the IPO of a bioelectronic medicine company.
Cannabis industry securities class action. Dismissal obtained.
An underwriter in a securities class action arising from an offering by a pharmaceutical company involving allegations regarding disclosures related to clinical trial results. Dismissal obtained.
Underwriters in a securities class action arising from an offering by a biotech company involving allegations of misrepresentations regarding the regulatory approval prospects for a drug candidate. Dismissal obtained.
Underwriters in a securities class action arising out of an offering by an electronic game company. Dismissal obtained.
Directors/officers of a multinational foreign financial institution in connection with a shareholder derivative litigation in which the plaintiff voluntarily dismissed the case while the motion to dismiss was pending.
A regional bank in a federal securities fraud class action. Dismissal obtained.
Several corporations in various investigations by the U.S. Department of Justice, U.S. Securities Exchange Commission and other government agencies.
Major international financial institutions in connection with mortgage-backed securities litigation matters.
Securities Industry and Financial Markets Association (SIFMA) as amicus curiae in a securities litigation matter.
A multinational foreign corporation in connection with cross-border discovery matters.
A multinational foreign financial institution in connection with investigations and settlement of claims regarding cross-border banking/tax issues by the U.S.
Department of Justice, U.S. Securities Exchange Commission and U.S. Internal Revenue Service.
Published Work
- Hoschander, Jeff (2023), Derivative Litigation and Pre-Suit Demands, Securities Litigation: A Practitioner’s Guide (Second Edition), (Practising Law Institute Treatise Chapter)
- Hoschander, Jeff, (2023) “Delaware Court of Chancery Rejects Stockholder Demand for Corporation to Supplement Its Section 220 Production with Searches and Production of Email”, The M&A Lawyer
- Hoschander, Jeff, (2023) “Delaware Court of Chancery Holds That Corwin Cleansing Does Not Apply to Claims for Injunctive Relief Related to Alleged Defensive Measures”, The M&A Lawyer
- Hoschander, Jeff, (2023) “Delaware Court of Chancery Dismisses Breach of Contract Claims Against Buyer, Finding Seller Retained Post-Closing Liability Related to Certain Product-Liability Litigations”, The M&A Lawyer
Awards
- “Future Star”, Benchmark Litigation, 2020-2023
Qualifications
Admissions
Courts
United States Court of Appeals for the Third Circuit, 2023
United States Court of Appeals for the Ninth Circuit, 2019
United States District Court for the Southern District of New York, 2009
United States District Court for the Eastern District of New York, 2009
United States District Court for the Eastern District of Michigan, 2023
Academic
J.D., New York University, 2006
M.D., Yale University, 2006